biote Corp.

biote Corp. completed its business combination with Haymaker Acquisition Corp. III, which traded on the Nasdaq under the ticker HYAC. The vehicle was sponsored by Haymaker Sponsor III, LLC and priced its IPO in 2021, targeting the healthcare sector. biote Corp. is a hormone health company that provides bioidentical hormone replacement therapy training, practitioner certification, and compounded pellet products to clinics and healthcare providers across the United States. Following the closing, the combined company began trading under the ticker BTMD on Nasdaq. For the full filing history, deal timeline, and analytics on biote and hundreds of other SPAC transactions, sign up for complete data access at SpacDesk.